20182018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Jole Ventriglia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 34 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Farolfi, A., Petrone, M., Scarpi, E., Gallà, V., Greco, F., Casanova, C., Longo, L., Cormio, G., Orditura, M., Bologna, A., Zavallone, L., Ventriglia, J., Franzese, E., Loizzi, V., Giardina, D., Pigozzi, E., Cioffi, R., Pignata, S., Giorda, G. & De Giorgi, U., 2018, In : Targeted Oncology. 13, 4, p. 469-479 11 p.

Research output: Contribution to journalArticle

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Farolfi, A., Petrone, M., Scarpi, E., Gallà, V., Greco, F., Casanova, C., Longo, L., Cormio, G., Orditura, M., Bologna, A., Zavallone, L., Ventriglia, J., Franzese, E., Loizzi, V., Giardina, D., Pigozzi, E., Cioffi, R., Pignata, S., Giorda, G. & De Giorgi, U., Aug 2018, In : Targeted Oncology. 13, 4, p. 469-479 11 p.

Research output: Contribution to journalArticle

  • Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

    Di Bartolomeo, M., Niger, M., Tirino, G., Petrillo, A., Berenato, R., Laterza, M. M., Pietrantonio, F., Morano, F., Antista, M., Lonardi, S., Fornaro, L., Tamberi, S., Giommoni, E., Zaniboni, A., Rimassa, L., Tomasello, G., Sava, T., Spada, M., Latiano, T., Bittoni, A. & 11 others, Bertolini, A., Proserpio, I., Bencardino, K. B., Graziano, F., Beretta, G., Galdy, S., Ventriglia, J., Scagnoli, S., Spallanzani, A., Longarini, R. & De Vita, F., Apr 2018, In : Targeted Oncology. 13, 2, p. 227-234 8 p.

    Research output: Contribution to journalArticle

  • Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

    Di Bartolomeo, M., Niger, M., Tirino, G., Petrillo, A., Berenato, R., Laterza, M. M., Pietrantonio, F., Morano, F., Antista, M., Lonardi, S., Fornaro, L., Tamberi, S., Giommoni, E., Zaniboni, A., Rimassa, L., Tomasello, G., Sava, T., Spada, M., Latiano, T., Bittoni, A. & 11 others, Bertolini, A., Proserpio, I., Bencardino, K. B., Graziano, F., Beretta, G., Galdy, S., Ventriglia, J., Scagnoli, S., Spallanzani, A., Longarini, R. & De Vita, F., Apr 2018, In : Targeted Oncology. 13, 2, p. 227-234 8 p.

    Research output: Contribution to journalArticle

  • Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

    Di Bartolomeo, M., Niger, M., Tirino, G., Petrillo, A., Berenato, R., Laterza, M. M., Pietrantonio, F., Morano, F., Antista, M., Lonardi, S., Fornaro, L., Tamberi, S., Giommoni, E., Zaniboni, A., Rimassa, L., Tomasello, G., Sava, T., Spada, M., Latiano, T., Bittoni, A. & 11 others, Bertolini, A., Proserpio, I., Bencardino, K. B., Graziano, F., Beretta, G., Galdy, S., Ventriglia, J., Scagnoli, S., Spallanzani, A., Longarini, R. & De Vita, F., Apr 1 2018, In : Targeted Oncology. 13, 2, p. 227-234 8 p.

    Research output: Contribution to journalArticle